Research Article Open Access

The Development of New Molecules Having Antiemetic Activity Using Molecular Modeling

Khalil Errahmane Kanouni1 and Yacine Benguerba2
  • 1 Sétif-1-University, Algeria
  • 2 Centre de Recherche en Biotechnologie (CRBt), Algeria


The solubility of a drug in water or in the blood represents the most desired parameter in medicine. Our aim is to obtain molecules with properties more effective than those of metoclopramide. In this work, two molecules with high solubility are constructed. Metoclopramide (a benzamide derivative) is a dopamine receptor antagonist used as an antiemetic drug. Its solubility in water is 200 mg/L at 25°C. In this work, we will develop two other molecules that have the same therapeutic activity of metoclopramide with a higher solubility in water, therefore in the blood, without affecting the other properties. The two molecules developed by molecular modeling with a chemical modification of the OH group of metoclopramide have a high solubility: approximately 3 times and 8 times that of metoclopramide. For the other physicochemical properties, there is a great similarity between the molecules. Thus, the two proposed molecules will have antiemetic activity, the second molecule will be more favorable because of its higher solubility and the number of HBA and HBD.

Current Research in Bioinformatics
Volume 8 No. 1, 2019, 21-28


Submitted On: 25 December 2019 Published On: 27 February 2020

How to Cite: Kanouni, K. E. & Benguerba, Y. (2019). The Development of New Molecules Having Antiemetic Activity Using Molecular Modeling. Current Research in Bioinformatics, 8(1), 21-28.

  • 0 Citations



  • Solubility
  • Drug
  • Metoclopramide
  • Antiemetic
  • Molecular Modeling